Investigation of SR-BI gene rs4238001 and rs5888 polymorphisms prevalence and effects on Turkish patients with metabolic syndrome

Author:

Filizfidan Mehmet1,Pence Sadrettin2ORCID,Çaykara Burcu1,Alsaadoni Hani1,Marakoğlu Kamile3,Pençe Halime Hanım4,Kargın Nisa Çetin3

Affiliation:

1. Istanbul University, Aziz Sancar Institute of Experimental Medicine (ASDETAE) , Department of Molecular Medicine , Istanbul , Turkey

2. Istanbul University, Aziz Sancar Institute of Experimental Medicine (ASDETAE) , Department of Molecular Medicine , Vakıf Gureba Cad 34093, Istanbul , Turkey

3. Selcuk University, Faculty of Medicine , Department of Family Medicine , Konya , Turkey

4. University of Health Sciences , Faculty of Medicine, Department of Medical Biochemistry , Istanbul , Turkey

Abstract

Abstract Aim Metabolic syndrome (MS) is associated with dyslipidemia such as hypertriglyceridemia and high-density lipoprotein (HDL) levels. Scavenger receptor BI (SR-BI) is the transmembrane receptor that regulates selective intake of cholesterol esters by the liver and it binds to HDL with high affinity. This study was aimed to determine the effects of SR-BI gen variations upon proatherogenic and antiatherogenic lipid profiles in the patients with metabolic syndrome. Methods The patient group was consisted of 104 (30–65 years) male subjects who were diagnosed with MS and 100 healthy male subjects were included in control group. DNA was isolated from blood samples. SR-BI gene rs4238001 and rs5888 variants were examined by SNaPshot multiplexing system. SPSS 18 was used for statistical analysis and p<0.05 considered as statistically significant. Results It was found that SR-BI gene rs4238001 T allele increased the risk of metabolic syndrome 1.61 fold (p=0.02). Subjects with TT genotype 2.847 fold increased the risk of metabolic syndrome according to subjects with CC genotype (p=0.017). Conclusions SR-BI rs4238001 variation may be related to an increased risk of metabolic syndrome.

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,Molecular Biology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3